Ceftazidime and Epivir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Epivir (lamivudine). Common drug interactions include blood lactic acid increased among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Epivir. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Epivir?

Epivir has active ingredients of lamivudine. It is often used in hiv infection. eHealthMe is studying from 16,870 Epivir users. Check the latest studies of Epivir.

On Jul, 12, 2026

39 people who take Ceftazidime and Epivir together, and have interactions are studied.

Ceftazidime and Epivir drug interactions.

What are the common drug interactions of Ceftazidime and Epivir, by gender? *:

female:

Blood lactic acid increased
Aspartate aminotransferase increased
Blood lactate dehydrogenase increased
Premature rupture of membranes
Anaemia neonatal
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Neonatal disorder (disease of neonates)
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
Complications of maternal exposure to therapeutic drugs

male:

Dysphagia (a condition in which swallowing is difficult or painful)
Pyrexia (fever)
Vocal cord paralysis
Weakness
General physical health deterioration (weak health status)
Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
Anaemia (lack of blood)
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
Emotional distress
Pain

What are the common drug interactions of Ceftazidime and Epivir, by age (0-1 to 60+)? *:

0-1:

Alanine aminotransferase increased
Blood creatinine increased
Premature baby
Blood lactic acid increased
Lipase increased
Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
Blood creatine phosphokinase increased
Blood lactate dehydrogenase increased
Anaemia neonatal
Premature rupture of membranes

2-9:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood creatine increased
Blood creatine phosphokinase increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Complications of maternal exposure to therapeutic drugs
Culture urine positive
Cytomegalovirus infection
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Lactic acidosis (low ph in body tissues)

10-19:

n/a

20-29:

Bone density decreased
Bone loss
Chronic kidney disease
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Tooth extraction
Tooth loss
Anxiety
Arthralgia (joint pain)
Bone pain

30-39:

Alanine aminotransferase increased
Anaemia (lack of blood)
Aspartate aminotransferase increased
Blood creatinine increased
Enterococcal infection
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypotension (abnormally low blood pressure)
Leukocytosis (increased white blood cells)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

40-49:

Rash
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septicaemia pseudomonal (blood infection by bacteria)
Sinusitis (inflammation of sinus)
Somnolence (a state of near-sleep, a strong desire for sleep)
Urinary tract infection
Vision blurred
White blood cell count decreased
Dysphagia (a condition in which swallowing is difficult or painful)

50-59:

Hypokalaemia (low potassium)
Renal impairment (severely reduced kidney function)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pain
Renal failure (kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Somnolence (a state of near-sleep, a strong desire for sleep)
Ascites (accumulation of fluid in the abdominal cavity)
Cell death
Chills (felling of cold)

60+:

n/a

What are the existing conditions these people have? *

Hiv Infection: 11 people, 28.21%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 15.38%
Pain: 3 people, 7.69%
High Blood Pressure: 3 people, 7.69%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.13%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 5.13%
Erection Problems: 2 people, 5.13%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Epivir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously